Hermann Heimpel

Q: What Schools Are Affiliated With Hermann Heimpel

Hermann Heimpel is affiliated with the following schools: University of Ulm, Ludwig Maximilian University of Munich, Charles University, Duke University, Heidelberg University

Hermann Heimpel's AcademicInfluence.com Rankings

Hermann Heimpel

Philosophy

#10546

Historical Rank

Logic

#5692

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Hermann Heimpel Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hermann Heimpel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group. (1994) (454)
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. (1991) (389)
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. (2003) (312)
Labor und Diagnose (2000) (311)
Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. (1989) (307)
Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. (1984) (299)
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. (2014) (269)
Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II (2009) (249)
Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count (1999) (249)
Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study. (1987) (226)
Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group. (1997) (222)
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group. (1993) (211)
Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. (1968) (179)
A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. (1995) (173)
Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. (1992) (172)
Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. (1989) (161)
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes (2004) (137)
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. (1988) (125)
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group. (1998) (118)
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. (2007) (113)
Congenital dyserythropoietic anemias: molecular insights and diagnostic approach. (2013) (110)
Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. (1995) (105)
The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients. (2005) (104)
T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome. (1987) (104)
Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. (2003) (103)
Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. (1990) (101)
Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis. (2002) (101)
[Congenital dyserythropoietic anemias]. (1975) (97)
Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. (2003) (97)
Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. (2006) (92)
Electron and light microscopic study of the erythroblasts of patients with congenital dyserythropoietic anemia. (1971) (91)
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure. (1999) (88)
Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea (2003) (84)
Anticoagulant-induced Pseudothrombocytopenia and Pseudoleucocytosis (1995) (84)
Hemopoietic reconstitution after bone marrow transplantation. (1986) (81)
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany (2009) (81)
Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. (1993) (80)
Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia. (1997) (76)
Ex vivo T‐cell depletion with the monoclonal antibody Campath‐1 plus human complement effectively prevents acute graft‐versus‐host disease in allogeneic bone marrow transplantation (1986) (74)
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies (2005) (74)
Epidemiology of rare anaemias in Europe. (2010) (73)
PRV-1 mRNA expression discriminates two types of essential thrombocythemia (2004) (72)
Congenital Dyserythropoietic Anaemia, Types I and II: Aberrant Pattern of Erythrocyte Membrane Proteins in CDA II, as Revealed by Two‐dimensional Polyacrylamide Gel Electrophoresis (1977) (72)
Granulocytic Progenitor Cells in Aplastic Anaemia (1977) (71)
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. (1995) (68)
Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease (2004) (66)
Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin's disease (1988) (64)
Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia – prospective long-term results from a randomized-controlled trial (2003) (61)
Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia. (1988) (60)
Quantitative analysis of cobblestone area-forming cells in bone marrow of patients with aplastic anemia by limiting dilution assay. (1996) (58)
Karyotypic evolution in patients with myelodysplastic syndromes. (1985) (58)
NATURAL-KILLER CELL-ACTIVITY IN PRE-LEUKEMIA (1982) (58)
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome (2000) (58)
Clozapine-induced agranulocytosis (2004) (57)
Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia. (1981) (57)
The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells (2010) (56)
Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations (2011) (55)
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score (1997) (55)
Changes of Granulopoiesis during and after Adjuvant Chemotherapy of Breast Cancer (1978) (55)
Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis (2004) (53)
Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II (2011) (51)
Some factors influencing granulocytic colony formation in vitro by human white blood cells. (1974) (50)
Drug-induced agranulocytosis: evidence for the commitment of bone marrow haematopoiesis. (2009) (48)
A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. (2011) (48)
Essential thrombocythemia and pregnancy. (1996) (46)
Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells. (1993) (46)
Proliferation disturbances of erythroblasts in congenital dyserythropoietic anemia type I and II. (1971) (45)
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment (2015) (45)
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia (2005) (44)
Antilymphocyte immunoglobulins stimulate peripheral blood lymphocytes to proliferate and release lymphokines (1990) (43)
Essential thrombocythemia in two sisters originating from different stem cell levels. (1990) (42)
EVIDENCE FOR THE INVOLVEMENT OF HOST‐DERIVED OKT8‐POSITIVE T CELLS IN THE REJECTION OF T‐DEPLETED, HLA‐IDENTICAL BONE MARROW GRAFTS (1987) (42)
Frequency of congenital dyserythropoietic anemias in Europe (2010) (42)
"Atypical" leukemias: preleukemia, smoldering leukemia and hypoplastic leukemia. (1984) (41)
Budd-chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases (1989) (41)
Growth and cytogenetic characteristics of bone marrow colonies from patients with 5q-syndrome. (1985) (39)
Coping and survival in patients with leukemia undergoing allogeneic bone marrow transplantation--long-term follow-up of a prospective study. (2005) (38)
Quantitative assessment of posttransplant host-specific interleukin-2-secreting T-helper cell precursors in patients with and without acute graft-versus-host disease after allogeneic HLA-identical sibling bone marrow transplantation. (1993) (38)
A phase I/II trial of recombinant human interleukin‐6 in patients with aplastic anaemia (1995) (38)
High levels of thrombopoietin in sera of patients with essential thrombocythemia: Cause or consequence of abnormal platelet production? (1998) (38)
Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients (1996) (37)
[Congenital dyserythropoietic anemia]. (2020) (37)
Randomized Comparison of Interferon-a With Busulfan and Hydroxyurea in Chronic Myelogenous Leukemia (2002) (34)
Serum erythropotietin and serum transferrin receptor levels in aplastic anaemia (1994) (34)
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate. (1995) (34)
Cell proliferation in the "preleukaemic" phase of acute leukaemia. A cytophotometric and autoradiographic study. (1972) (34)
Drug-induced aplastic anaemia: clinical aspects. (1980) (33)
[Congenital dyserythropoietic anemia in a pair of dizygotic twins]. (1967) (32)
Randomized Comparison of Imatinib 800 Mg Vs. Imatinib 400 Mg +/- IFN in Newly Diagnosed BCR/ABL Positive Chronic Phase CML: Analysis of Molecular Remission at 12 Months; The German CML-Study IV. (2009) (32)
Toward the harmonization of result presentation for the eosin‐5′‐maleimide binding test in the diagnosis of hereditary spherocytosis (2014) (31)
Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia (1997) (31)
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. (1989) (30)
Micromegakaryocytes in Human Bone Marrow. (1980) (30)
Current aspects of drug therapy in Philadelphia-positive CML: correlation of tumor burden with survival. (1996) (29)
Roferon (rIFN-α2a) Is More Immunogenic Than Intron A (rIFN-α2b) in Patients with Chronic Myelogenous Leukemia (1994) (29)
Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease. (1995) (29)
Hematological side effects of co-trimoxazole (2005) (28)
Glycolipids and glycopeptides of red cell membranes in congenital dyserythropoietic anaemia type II (CDA II) (1987) (28)
Human parvovirus infection. (1986) (27)
Drug-Induced Agranulocytosis (1988) (27)
IDENTIFICATION OF HIGH-RISK PATIENTS WITH APLASTIC ANÆMIA IN SELECTION FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (1976) (26)
Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia. (1990) (26)
Idiopathic myelofibrosis: a retrospective study of 103 patients. (1990) (26)
Paroxysmal Nocturnal Haemoglobinuria: A Replacement of Haematopoietic Tissue? (2000) (26)
Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta‐analysis of three randomized trials (2000) (26)
Quantitative Estimation of Human Serum Haptoglobins by an Immunological Method (1965) (25)
Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia. (1987) (25)
Pathophysiology of Aplastic Anaemia (1975) (25)
Role of whole body FDG-PET imaging in predicting relapse of malignant lymphoma in patients with residual masses after treatment (1999) (25)
Geographic distribution of CDA-II: did a founder effect operate in Southern Italy? (2000) (24)
When should the clinician suspect a drug‐induced blood dyscrasia, and how should he proceed? (1996) (24)
Megakaryocyte Polyploidization in Acute Leukaemia and Preleukaemia (1974) (24)
Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern blot analysis. German chronic myeloid leukaemia (CML) Study Group. (1997) (24)
Usefulness of FDG-PET in diagnosing primary lymphoma of the liver. (1997) (23)
The role of granulocytes in colony stimulation by human white blood cells in agar cultures. Enhancement and inhibition of CSA. (2009) (23)
Acute lymphoblastic leukemia in patients over 59 years of age (1994) (22)
Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation. (1993) (22)
Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS) (2008) (21)
The evaluation of serial measurements of the NK cell activity in man. (1983) (21)
Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy (2006) (21)
Cytogenetic studies in chronic myeloproliferative disorders. (1983) (21)
Successful therapy with donor buffy coat transfusions in patients with relapsed chronic myeloid leukemia after bone marrow transplantation is associated with high frequencies of host-reactive interleukin 2-secreting T helper cells. (1995) (21)
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group. (1996) (20)
Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F (2007) (20)
Polycythemia vera. A clinical study of 141 patients (1989) (19)
Erythroid Colony Forming Cells in Aplastic Anaemia (1977) (19)
New diagnostic imaging procedures in Hodgkin's disease. (1996) (19)
In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia. (1990) (19)
Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation. (1988) (18)
The abundant presence of Söderström bodies in cytology smears of fine-needle aspirates contributes to distinguishing high-grade non-Hodgkin's lymphoma from carcinoma and sarcoma (1997) (18)
Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype‐phenotype correlations (2016) (18)
Acute lymphoblastic leukemia in patients over 59 years of age. Experience in a single center over a 10-year period. (1994) (18)
The early loss of radioactivity in Cr51 survival curves: destruction of cells or loss of the label? (1965) (18)
Induction of myeloperoxidase in five cases of acute unclassified leukaemia (1988) (17)
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1. (1993) (17)
Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer (2006) (17)
ABO-incompatible bone marrow transplantation. (1992) (17)
Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes. (1985) (16)
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha. (2003) (16)
Erythropoietic cell proliferation in different clinical states of -thalassaemia. (1971) (16)
[Dyserythropoiesis and dyserythropoietic anemias]. (1975) (16)
Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia. (1996) (16)
Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantation. (1996) (16)
Extramedullary haemopoiesis after bone marrow transplantation. (2009) (16)
Some characteristics of the proliferative activity of erythroblasts in untreated and treated acute leukaemia. (1973) (15)
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon α (2003) (15)
A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia (1989) (15)
T‐cell depletion versus methotrexate as GvHD‐prophylaxis in allogeneic bone marrow transplantation for leukaemia (1988) (14)
Serum Erythropoietin and Thrombopoietin Levels in Patients with Essential Thrombocythaemia (2000) (14)
Idiopathic combined immunocytopenia (1985) (14)
Multizentrische Ermittlung von Referenzbereichen für Parameter des maschinellen Blutbildes/Multicentric Determination of Reference Ranges for Automated Blood Counts (2011) (14)
Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantation. (1993) (14)
Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival (1992) (13)
[A case-based and multi-media computer learning program on the topic of myocardial infarct, angina pectoris and mitral valve stenosis]. (1996) (13)
Lymphokines as inhibitors of hematopoietic cell proliferation. (1988) (13)
[Blood clotting factor XIII substitution in acute leukaemia: result of a randomized and controlled study]. (2008) (13)
CYCLOSPORINE AS AN ALTERNATIVE TO CYCLOPHOSPHAMIDE IN THE TREATMENT OF CHRONIC GRAFT‐VERSUS‐HOST DISEASE (1986) (13)
High-titre interferon-alpha antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. (1994) (13)
Gonadal function after bone marrow transplantation in adult male and female patients. (1991) (13)
Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approaches. (1989) (13)
Characteristics of the Late Middle Ages in Germany (1972) (13)
[Ultrasound guided fine- and coarse-needle puncture of the abdominal and retroperitoneal space]. (1987) (13)
The Turnover of Blast Cells in Peripheral Blood After in vitro3H‐Cytidine Labelling and Retransfusion in Human Acute Leukaemia * (1972) (13)
[Recirculation of lymphocytes in patients with malignant lymphatic systemic diseases]. (1972) (13)
CD 54 expression and its role in homotypic aggregation of the blasts of acute myeloblastic leukemias (AML). (1994) (12)
Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia (2009) (12)
Molecular response of CML patients treated with interferon‐α monitored by quantitative Southern blot analysis (1997) (12)
Randomized Comparison of Imatinib 400 Mg Vs. Imatinib + IFN Vs. Imatinib + AraC Vs. Imatinib after IFN Vs. Imatinib 800 Mg: Optimized Treatment and Survival. Designed First Interim Analysis of the German CML Study IV (2008) (12)
Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany. (1985) (12)
Capillary leak syndrome associated with elevated IL-2 serum levels after allogeneic bone marrow transplantation (2005) (12)
Congenital dyserythropoietic anemia in a Chinese family with a mutation of the CDAN1-gene (2008) (12)
Prospective randomized clinical study in general surgery comparing a new low molecular weight heparin with unfractionated heparin in the prevention of thrombosis (1994) (12)
Randomized Comparison of Interferon-{alpha}, Hydroxyurea, and Busulfan in Chronic Myeloid Leukemia: Response to Kantarjian and Talpaz and to Tura and Baccarani (1995) (12)
Conventional Morphological Examination of Blood and Bone Marrow Cells in the Diagnosis of Preleukemic Syndromes (1979) (11)
NATURAL KILLER CELL ACTIVITY IN PRELEUKAEMIA (1982) (11)
Antimicrobial prophylaxis in acute leukaemia: Prospective randomized study comparing two methods of selective decontamination (1983) (11)
Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation (2005) (11)
Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-α and IFN-β antibodies (1994) (11)
Aplastic Anemia: Epidemiology and etiology of aplastic anemia (1999) (11)
Impaired T-cell and NK-cell function in patients with preleukemia (1982) (11)
Immunoglobulin substitution therapy in a patient with primary hypogammaglobulinaemia and anti‐IgA antibodies (1986) (11)
Molecular Response After 3 Months of 1st Line Imatinib Therapy Is Predictive for Treatment Failure and Disease Progression In Patients with Chronic Phase Chronic Myeloid Leukemia - a Follow-up Analysis of the German CML Study IV (2010) (11)
[Fibrin pleurodesis in malignant pleural effusions]. (2008) (11)
The present state of pathophysiology and therapeutic trials in polycythemia vera. (1996) (10)
[Prevention of infections and thromboses after splenectomy or because of functional loss of the spleen]. (2009) (10)
Acute hematotoxicity of oral benzo(a)pyrene: the role of the Ah locus. (1986) (10)
[The isolation bed system for the prevention of infection in reduced resistance. Its application in intensive chemotherapy for hemoblastoses]. (1969) (10)
Vitamin B12-Responsive Pancytopenia Mimicking Myelodysplastic Syndrome (2011) (9)
Adjuvant chemo(immuno-)-therapy of primary breast cancer with adriamycin-cyclophosphamide (and levamisole)--six-year evaluation. (1983) (9)
The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia (1980) (9)
Pseudoreticulocytosis in a patient with myelodysplasia (1993) (9)
Hematopoietic colony formation after allogeneic bone marrow transplantation: enhancement by cyclosporin A and anti-gamma-(immune) interferon antiserum in vitro. (1986) (9)
Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor (1975) (9)
Different antitumor mechanisms of interferon‐alpha in the treatment of hairy cell leukemia and renal cell cancer (1988) (9)
Chronic myelogenous leukemia : recent developments in prognostic evaluation and chemotherapy (1992) (9)
Aplastic Crisis as a Complication of Congenital Dyserythropoietic Anemia Type II (2006) (9)
Blast crisis of Philadelphia chromosome-positive chronic myelocytic leukemia (CML) (1988) (9)
Unclassified type of congenital dyserythropoietic anaemia (CDA) with prominent peripheral erythroblastosis (1985) (9)
Reaction of human granulopoiesis to high-dose cyclophosphamide therapy (1979) (9)
Chronic Myeloproliferative Disorders: A Clinician’s View (2004) (8)
Randomized Comparison of Primary Allogeneic Stem Cell Transplantation and Best Available Drug Treatment in Chronic Myeloid Leukemia. (2006) (8)
Low-dose Ara-C in the treatment of acute leukemia cytotoxicity or differentiation induction? (1984) (8)
Emergence of CD 52-, Phosphatidylinositolglycan-Anchor-Deficient T Lymphocytes After In Vivo Application of Campath-1 H for Refractory B-Cell Non-Hodgkin Lymphoma (2000) (8)
Deficient IFNα production in hairy cell leukemia (1986) (8)
Human placenta-conditioned medium for stimulation of human granulopoietic precursor cell (CFU-C) colony growth in vitro (1978) (8)
[THE DETERMINATION OF HUMAN ERYTHROCYTE SURVIVAL TIME WITH RADIOACTIVE DIISOPROPYLFLUOROPHOSPHATE (DFP32) AND ITS USE IN CLINICAL PRACTICE]. (1964) (8)
Aplastic anemia. Pathophysiology and approaches to therapy. (1979) (8)
Aplastic Anemia before Bone Marrow Transplantation and Antilymphocyte Globulin (2000) (7)
Cryocrystalglobulinemia: pH-dependent precipitation of a monoclonal IgG-kappa-immunoglobulin (1989) (7)
[Functional disorders of the hematopoietic system in the preleukemic phase of acute undifferentiated leukemia]. (1972) (7)
Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia (2004) (7)
The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation. (1985) (7)
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha (1988) (7)
A case of preleukemia — Reconstitution of normal marrow function after bone marrow transplantation (BMT) from identical twin (1979) (7)
Feasibility of Imatinib Combination Therapies in a Randomized Trial for Chronic Myeloid Leukemia: The German CML-Study IV - Pilot Phase. (2004) (7)
BONE-MARROW CELLS RESISTANT TO CHLORAMPHENICOL IN CHLORAMPHENICOL-INDUCED APLASTIC ANÆMIA (1975) (7)
CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis (2018) (7)
[Acute drug-induced agranulocytosis: comparison between openward treatment and antimicrobial decontamination in a plastic isolation bed system (retrospective study of 30 cases) (author's transl)]. (1978) (7)
Strategy for the treatment of hairy cell leukemia. (1987) (7)
Adjuvant intermittent chemoimmunotherapy for primary breast cancer: a prospective study with immunologic follow-up. (1982) (7)
Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patients (1998) (6)
[Drug therapy for pain in cancer patients]. (1981) (6)
Haemolytic anaemia as initial manifestation of wilson's disease (2004) (6)
[Immunoblastic lymphadenopathy--malignant neoplasia or hyperimmune reaction? (author's transl)]. (1977) (6)
Sodium Pertechnetate as a Red Cell Label: In Vitro and In Vivo Studies (1976) (6)
Infection prophylaxis in acute leukaemia patients: comparison of selective and total antimicrobial decontamination of the gastrointestinal tract. (1982) (6)
Allogenic bone marrow transplantation of chemotherapy for patients with acute myeloid leukemia in first complete remission: a decision analysis approach (1996) (6)
TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen. (1986) (6)
Professional treatment in the context of medical pluralism—A German perspective (2010) (6)
[Clinical results with a new intravenous immunoglobulin preparation (author's transl)]. (2008) (6)
In vitro and in vivo depletion of T cells. (1993) (6)
Treatment of refractory chronic idiopathic thrombocytopenic purpura with high dose intravenous immunoglobulin (1984) (6)
Letter: Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced aplastic anaemia. (1975) (6)
Deficient IFN alpha production in hairy cell leukemia. (1986) (6)
[The effect of mesterolone in panmyelopathic anemia and anemia of renal failure]. (1976) (6)
[A new variant of the congenital dyserythropoietic anemia]. (1967) (6)
Disseminated mycobacterial histiocytosis due to M. fortuitum associated with helper T-lymphocyte immune deficiency (2004) (6)
Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1G208R mutation (2011) (5)
Platelet-adjusted IFN dosage in the treatment of advanced hairy cell leukemia (1985) (5)
Recommendations for Centres of Expertise in Rare Anaemias. The ENERCA White Book (2014) (5)
[Counting reticulocytes: new importance of an old method]. (2010) (5)
Stimulation of hemopoiesis in aplastic anemia by hormones and other agents. (1979) (5)
Intensive care therapy for patients with hematological diseases. (1987) (5)
Fragmentozyten im peripheren Blut Fragmented cells in peripheral blood (2005) (5)
Autologous platelet transfusion in alloimmunized patients with acute leukemia (1995) (5)
[Immunosuppressive therapy in panmyelopathy. Experiences with various forms of therapy in 42 patients]. (2008) (5)
Optimaization of Imatinib Therapy by Combination. 5 Year Survival and Response Results of the Pilot Phase of the Randomized German CML STUDY IV. (2009) (5)
Complete Molecular Remission (CMR 4.5) of CML Is Induced Faster by Dose – Optimized Imatinib and Predicts Better Survival - Results From the Randomized CML-Study IV (2012) (5)
Allogeneic bone marrow transplantation for myelodysplastic syndromes (MDS). (1989) (5)
Dysplasia of the lymphatics with lymphoedema, generalized lymphangiectasis, chylothorax and "pseudo-storage-disease". (1979) (5)
[Problems of adult sickle cell patients in Germany]. (2009) (5)
[Long-term substitution with platelets in patients with aplastic anemia and severe thrombocytopenia (author's transl)]. (1973) (5)
Spontaneous interferon-α antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas (1991) (5)
HEMATOLOGICAL FEATURES OF ANOREXIA-NERVOSA (1977) (5)
Book reviews (2004) (5)
Concentration of bone marrow mononuclear cells for in vitro treatment and AB0-incompatible transplantation: a rapid and reproducible procedure using the haemonetics V50 cell separator. (1988) (5)
[Megakaryocyte polyploidization in acute leukemia and preleukemia]. (1973) (5)
The relationship of lytic effects against autologous and allogeneic PHA blasts induced in human mixed lymphocyte cultures. (1984) (5)
Modified immunocytochemical slide technique for demonstrating surface antigens on viable cells. (1985) (5)
The clinical efficacy of granulocyte transfusions: Studies on the oral cavity (1977) (4)
Interferon in chronic myeloid leukemia (1993) (4)
Diagnosis and clinical course of congenital dyserythropoietic anaemia type 1 in a 12-year-old girl (2001) (4)
Towards the harmonization of result presentation for the eosin-5'- maleimide (EMA) binding test in the diagnosis of hereditary spherocytosis. (2014) (4)
Concept, Feasibility and Results of the Randomized Comparison of Imatinib Combination Therapies for Chronic Myeloid Leukemia: The German CML-Study IV. (2005) (4)
[Determination of thrombocyte survival time with 51Cr. II. Studies on the survival time of autologous thrombocytes in patients with pronounced thrombopenia]. (1970) (4)
[Hemolytic-uremic syndrome in adults]. (1973) (4)
Granulocyte transfusions in acute leukaemia. Regeneration of granulopoiesis as determining factor of survival. (2009) (4)
STEPWISE ANALGESIC THERAPY REGIMEN FOR CHRONIC CANCER PAIN (1983) (4)
Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin (1986) (4)
[Panmyelopathy after administration of diclofenac?]. (1979) (4)
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group. (1997) (4)
Daunomycin, cytosin-arabinoside and VP-16 (DAV) for myeloid blast crisis of CML (1989) (4)
Tests for Diagnosis of Preleukemic States Round Table Discussion (1979) (4)
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia (2014) (4)
A new type of transfusion-dependent congenital dyserythropoietic anemia (2007) (4)
[Drug-induced panmyelopathies]. (1976) (4)
[Fall Congress for Integrative Medicine--model for the future]. (2009) (4)
HTLV III antibodies and immunological alterations in hemophilia patients (1986) (4)
Measurement of recipient-specific alloreactivity: is GVHD predictable? (1993) (4)
Granulocytic and erythroid progenitor cells in recovering aplastic anemia. (1979) (4)
Comments on the paper by Krech and Thiele. "Histopathology of the bone marrow in toxic myelopathy. A study of drug induced lesions in 57 patients". (1986) (4)
A Dyserythropoietic Anemia Associated with Homozygous Hb Plasencia [α125(H8)Leu→Arg (α2)] (HBA2:c.377T>G), A Variant with an Unstable α Chain (2010) (3)
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia — initial results (1993) (3)
Risk groups in adult acute lymphoblastic leukemia. (1987) (3)
IN-VITRO EFFECTS OF VISCUM-ALBUM (L) EXTRACTS ON LEUKEMIC BLAST CELLS AND ON CULTURED PERIPHERAL-BLOOD MONONUCLEAR-CELLS - COMMENTS (1995) (3)
[Cyclosporin A in the therapy of hematologic diseases]. (2008) (3)
Aplastic anaemia: residue analysis of chlorinated hydrocarbons in human bone marrow biopsy specimens by high resolution gas chromatography. (1985) (3)
Y-chromatin: method to study a take or rejection after bone marrow transplantation. (1980) (3)
BLOOD RADIATION DOSE AND HAEMATOLOGICAL FINDINGS DURING RADIOACTIVE IODINE THERAPY OF HYPERTHYROIDISM, EUTHYROID GOITRE AND THYROID CANCER (1967) (3)
In vitro and in vivo studies on filter collected granulocytes. (2009) (3)
[On the symptomology of familial megaloblastic anemia with proteinuria]. (1967) (3)
INFECTION PROPHYLAXIS IN BONE-MARROW TRANSPLANTATION (BMT) WITH 2 DIFFERENT METHODS OF GNOTOBIOTIC CARE (1983) (3)
Alcohol-associated diseases in internal medicine: A screening study on 1494 medical emergency patients (1998) (3)
Measurement of cell mediated cytotoxicity by post-labeling surviving target cells. (2008) (3)
New perspectives with interferon alpha. The German CML study group experience. (1994) (3)
Education of lymphocytes in vivo following a transient take of a matched unrelated bone-marrow graft in man. (1977) (3)
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Aplastic Anemia: A Phase I/II Trial with Emphasis on Very Severe Neutropenia and Active Infection (1992) (3)
Multi-centric determination of reference ranges for automated blood counts 1 (2011) (3)
Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemopheliacs and other patients chronically substituted with blood products (1985) (3)
Aggressive polychemotherapy for acute myelofibrosis (1990) (3)
TREATMENT OF SEVERE ACUTE GVHD WITH HIGH-DOSE ATG (1983) (3)
Granulocytic colony forming cells in vitro: I. Patients with drug induced agranulocytosis (1977) (3)
Quantitative and Functional Studies of Lymphocyte Subpopulations During Adjuvant Chemo(immuno)therapy in Patients with Breast Cancer (1979) (3)
Granulocyte–Macrophage Colony-Stimulating Factor in the Therapy of Adults with De Novo Acute Myeloblastic Leukemia: An Update of a Double-Blind Randomized, Placebo-Controlled Trial (1997) (3)
[Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)]. (1978) (3)
High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia (1995) (3)
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia. (1994) (3)
Aplastic anaemia after naproxen? (1980) (3)
Biallelic heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia (1986) (3)
[Immunoblastic lymphadenopathy with a pseudoleukemic blood picture]. (1976) (3)
Idarubicin, Cytosine Arabinoside and Etoposide for Relapsed or Refractory Acute Myeloid Leukemia (1992) (2)
Adjuvant intermittent chemo-immunotherapy of breast cancer. A prospective study. (1980) (2)
[The determination of thrombocyte survival with Cr51. I. Studies on the binding of radioactive sodiumchromate (Na2 51Cr4) to thrombocytes in vitro]. (1969) (2)
[Simulation of a mediastinal non-Hodgkin lymphoma recurrence by a diffuse thymus hyperplasia in 18F-FDG PET scan]. (1996) (2)
T-helper cells: Their role in the pathogenesis of graft-versus-host disease and graft-versus-leukemia effect (1996) (2)
Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation. (1976) (2)
Peroxidase expression in acute unclassified leukemias: ultrastructural studies in combination with immunophenotyping. (1994) (2)
[Haematological features of anorexia nervosa (author's transl)]. (1977) (2)
Variations in the susceptibility to lysis of NK target cells. (1984) (2)
Functional criteria for staging and treatment of hairy cell leukemia. (1991) (2)
[Splenomegaly yesterday and today]. (1984) (2)
[Anemias caused by impaired production of erythrocytes]. (1977) (2)
Blood group change in a patient with blastic transformation of a myelodysplastic syndrome (1987) (2)
Interferon Alpha in the Treatment of Malignant Diseases: Sources, Doses, and Regimens (1987) (2)
[Aplastic and hypoplastic bone marrow diseases]. (1974) (2)
Granulocyte-macrophage colony-stimulating factor in the sera of patients with aplastic anemia (1993) (2)
Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation (1987) (2)
Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-alpha and IFN-beta antibodies. (1994) (2)
[Macrocytosis caused by alcohol and/or drugs]. (1987) (2)
Differentiation into Granulopoiesis in Human Acute Leukemia and Blast Crisis in Chronic Myelocytic Leukemia (1980) (2)
APLASTIC ANÆMIA AFTER NAPROXEN? (1980) (2)
[Significance of 2,3-diphosphoglycerate for the oxygen affinity of hemoglobin]. (1971) (2)
Significance of teardrop cells in peripheral blood smears (2014) (2)
Molecular Analysis of the SEC23B Gene In Patients Affected by Congenital Dyserythropoietic Anemia Type II (CDAII) (2010) (2)
[Bone marrow transplantation as therapy in chronic myeloid leukemia]. (2008) (2)
Acta Concilii Constanciensis (1929) (2)
[Successful treatment of recurrent lower gastrointestinal hemorrhage in intestinal angiodysplasia with an estrogen-progesterone combination]. (1993) (2)
Interferon in chronic myeloid leukemia. A workshop report. (1993) (2)
Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group. (1992) (2)
[Recruiting patients and results of a preliminary study on the therapy of acute lymphatic leukemia and acute undifferentiated leukemia in adults]. (1983) (2)
management and outcome of Cml-blast crisis: Results from the randomized Cml study Iv : V907 (2014) (2)
[Positive acid serum test and elevated agglutinability by Anti-i in patients with congenital dyserythropoietic anemia]. (1970) (1)
Prevention of Acute GvHD in Allogeneic Bone Marrow Transplantation by in vitro Treatment with the Monoclonal Anti-Lymphocyte Antibody Campath-1 (1985) (1)
Granulocytic colony forming cells in vitro: II. Patients with aplastic anaemia (1977) (1)
Chronic Myeloproliferative Syndromes: Initial Findings, Evolution, and Prognosis in 489 Patients (1993) (1)
Induction of early myeloperoxidase in acute unclassified leukemia. (1987) (1)
[HEREDITARY ELLIPTOCYTOSIS WITH HEMOLYTIC ANEMIA. CLINICAL CURE BY SPLENECTOMY]. (1963) (1)
Pretreatment Expression Levels of MDR1 and OCT-1 Predict Response to First Line Imatinib Treatment In Chronic Phase CML Patients (2010) (1)
In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients. (2006) (1)
[Reaction of the human granulopoiesis to large doses of cyclophosphamide]. (1978) (1)
EPIDEMIOLOGY OF RARE ANAEMIAS IN EUROPE ( 1 ) (2012) (1)
A Prospective Study of Patients with Preleukemia (1979) (1)
Transient pancytopenia (1990) (1)
Dietrich von Niem (c. 1340-1418) (1932) (1)
Technetium-Labeled Red Cells (1973) (1)
Contents 18, No. 2, 1995 (1995) (1)
Modulation of in vitro production of tumor necrosis factor lymphotoxin and interferon gamma induced by recombinant interferon in vivo (1986) (1)
[Age-independent increase in cancer prevalence in Sweden?]. (1993) (1)
[Course and prognosis of panmyelopathy and isolated aplastic anemia. Retrospective study in 70 patients]. (1975) (1)
Agranulocytosis after BMT (1985) (1)
Polycythemia Vera: Perspectives for Future Clinical Trials (1995) (1)
GRAFT REJECTION AFTER SYNGENEIC BONE MARROW TRANSPLANTATION FOR APLASTIC ANAEMIA: SIGNIFICANCE OF COCULTURE STUDIES (1985) (1)
Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts (2012) (1)
Treatment results of nine patients with burkitt's lymphoma (1986) (1)
Cytomegalovirus immunoglobulin g hyperimmunoglobulin for the prevention of cytomegalovirus infection in bone marrow transplantation recipients (1986) (1)
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Related Donor in Chronic Myeloid Leukemia (CML): An Explanation for Fast Improvement of Survival in Two Consecutive German CML Studies. (2009) (1)
[Bone marrow necrosis in acute leukemias]. (1988) (1)
Treatment of symptomatic HIV infection with oral diphenylhydantoin (1988) (1)
Activating Mutation of Heme Oxygenase (HO)-1: A Novel Disease Entity Characterized by Microcytic, Hemolytic Anemia, a Defect of Bilirubin Synthesis and Hereditary Hemophagocytic Lymphohistiocytosis. (2007) (1)
[Evaluation of 196 patients with chronic myeloid leukemia based on a standard prognosis model]. (1990) (1)
[First experience with the practical year in internal medicine (author's transl)]. (1977) (1)
Cytogenetic Studies in Acute Leukemia and in the Blast Phase of the Chronic Myelocytic Leukemia (1985) (1)
Congenital Dyserythropoietic Anaemia Type I: Clinical and Experimental Aspects (2008) (1)
[Endocarditis caused by Haemophilus parainfluenzae and Neisseria gonorrhoeae]. (1987) (1)
Annual congress of the Austrian and German societies of hematology and oncology Vienna, October 6–9, 1985 Abstracts (2004) (1)
Enrichment of hematopoietic progenitor cells from human bone marrow on percoll density gradients (1982) (1)
[Comparative morphological and cytophotometric-autoradiographical study of erythropoiesis in man]. (1971) (1)
Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group. (1993) (1)
Improvement of preparative conditions for cytogenetic studies by short-term liquid culture of haemopoietic cells (1977) (1)
Cryopreserved autologous platelet transfusions in alloimmunized patients with acute leukemia. (1992) (1)
Congenital dyserythropoietic anemias: clinical manifestations and new observations on epidemiology, pathogenesis and therapy (1999) (1)
[Electrocardiographic studies on the effect of halothane on the heart]. (1959) (1)
Clinical Trials Underestimate Age of Chronic Myeloid Leukemia (CML) Patients: Epidemiological Study in a Representative Area in Germany. (2007) (1)
[Diagnosis of hemolysis and differential hemolytic anemia diagnosis]. (1998) (1)
Neutrophil PRV-1 mRNA Overexpression in Chronic Idiopathic Myelofibrosis May Be Associated with Poor Prognosis. (2004) (0)
Clinical relevance of endocrine and reproductive dysfunctions in patients after bone marrow transplantation (1988) (0)
clinical appearance, and prognosis based on long-term observation Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, (2013) (0)
Book reviews (1984) (0)
[Determination of plasma iron -- useful, superfluous, or misleading?]. (2003) (0)
[Drugs and agranulocytosis]. (1979) (0)
Book reviews (2005) (0)
Supportive Therapy and Bone Marrow Transplantation in MDS (1992) (0)
In vivo/ex vivo T-cell depletion with anti-CD52 monoclonal antibodies: long-term results in patients with acute leukaemia in CR1 (2004) (0)
[Treatment of panmyelopathies]. (1979) (0)
[Contribution of internal medicine to education of medical students]. (1993) (0)
Effect of Cyclosporine on the Frequency of LAK Precursor Cells In Vivo and In Vitro (1992) (0)
E. W. und A. I. Carlyle, A History of Mediaeval Political Theory in the West, vol. VI: Political Theory from 1300 to 1600 (1938) (0)
[Fe59 studies on the iron uptake hemoglobin formation in reticulocytes]. (1965) (0)
High-intensitytherapyversuslow-intensitytherapy inadvancedbreastcancerpatients (1990) (0)
HEINRICH FINKE: EIN NACHRUF (1939) (0)
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia. (1996) (0)
Book reviews (2004) (0)
[Intensive combined therapy for high-risk ALL patients]. (1988) (0)
nonsense mutation in the A novel type of congenital hypochromic anemia associated with a (2012) (0)
Letter from the editor (2004) (0)
marrow transplantation graft-versus-host disease after allogeneic HLA-identical sibling bone secreting T-helper cell precursors in patients with and without acute Quantitative assessment of posttransplant host-specific interleukin-2- (2011) (0)
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]. (1987) (0)
[The assessment of therapeutic success in chronic myeloid leukemia]. (1995) (0)
[Immune leukocytopenia]. (1970) (0)
[Therapy of malignant testicular tumors]. (1977) (0)
[Estimation and clinical significance of the surface activity measurement following radiochromium labeling of erythrocytes]. (1963) (0)
Interferon-α in the Treatment of CML: Comparison of Busulfan versus Hydroxyurea versus Interferon-α (1994) (0)
Book reviews (1983) (0)
Book reviews (1984) (0)
Faculty of 1000 evaluation for Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update. (2012) (0)
MEDICAL THEORY AND ACTING AS PHYSICIAN IN THE CLINICAL MEDICAL-EDUCATION - EXPERIENCES DURING CLERKSHIP IN INTERNAL-MEDICINE (1993) (0)
Subject Index Vol. 18, 1995 (1995) (0)
[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study]. (1979) (0)
Blast Transformation and DNA Synthesis in Lymphocyte Cultures from Patients with Aplastic Anaemia (1972) (0)
Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Commentary (2007) (0)
[Severe tetraparesis as the first manifestation of a chronic lymphatic leukemia]. (1992) (0)
[Plasma cell leukemia. Report of 5 cases]. (1976) (0)
[RESEARCH ON ERYTHROCYTE CHANGES IN 50 PATIENTS WITH PRIMARY PANMYELOPATHY]. (1964) (0)
Book reviews (1986) (0)
[Recombinant tissue-type plasminogen activator: pharmacokinetics and effect on the hemostasis system of the human]. (1988) (0)
[Essential thrombocythemia. Clinical significance, diagnosis and therapy]. (1993) (0)
[Is the Approbation Act as bad as its reputation? Views on the reform of medical education]. (1975) (0)
No more transplantation in CML? Authors' reply (2007) (0)
[Immune thrombocytopenia]. (1970) (0)
[Blastic transformation and DNA synthesis in lymphocyte cultures from patients with aplastic anemia (panmyelopathy)]. (1970) (0)
[The 10-minute consultation: anemia as a chance finding]. (2004) (0)
globulin with or without cyclosporine A for treatment of aplastic anemia Eleven years follow-up of a randomized trial comparing antithymocyte (2013) (0)
The use of 99m-Tc-Pertechnetate for the determination of red cell volume (1973) (0)
[Investigations on the synthesis of heme in red blood corpuscles. I. Formation of Fe59 hemoglobin in hemolysates and suspensions of rabbit reticulocytes. Utilization of a precipitation method for the isolation of iron in heme]. (1965) (0)
Seide aus Regensburg (1954) (0)
[Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982]. (1985) (0)
[Anemias. General views on pathogenesis, diagnosis and therapy]. (1977) (0)
[A problem of differential diagnosis: anemia of unknown origin]. (2007) (0)
Faculty Opinions recommendation of Evidence for a proatherogenic biochemical phenotype in beta thalassemia minor and intermedia. (2011) (0)
[10 minute consultation: thrombocytosis as an incidental finding]. (2004) (0)
Book reviews (2004) (0)
[Summary: Panmyelopathy: a disease picture with heterogeneous pathogenesis]. (1980) (0)
Results and diagnostic significance of ferrokinetic investigations in iron deficiency and in the anaemia of infection with sideropenia (1967) (0)
Contents, Vol. 76, 1986 (1986) (0)
[Treatment of bone metastases of breast cancer]. (1987) (0)
Interferon-α: Its Current Clinical Utility and Future Perspectives (1997) (0)
[Aspiration and needle biopsy on the posterior iliac crest. A simple technic for diagnostic bone marrow collection]. (1978) (0)
[Gamma-D-paraproteinemia in plasmacytoma]. (1967) (0)
[Etiology and pathogenesis of panmyelopathy]. (1979) (0)
Establishment and characterization of a new Epstein-Barr virus transformed cell line from a human B cell lymphoma (1990) (0)
Book reviews (2005) (0)
[THE LOCALIZATION OF ERYTHROCYTE DEGRADATION IN AUTOIMMUNE HEMOLYTIC ANEMIAS. STUDIES WITH CR51]. (1964) (0)
Book reviews (1982) (0)
[Distribution of haemoglobin content in human red cells, estimated by scanning cytophotometry (author's transl)]. (1977) (0)
Effect of national and locally owned guidelines on medical practice (2003) (0)
[Effect of preparation and preservation modality on thrombocyte quality]. (1993) (0)
RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - PHARMACOKINETICS AND INTERACTION WITH THE FIBRINOLYTIC SYSTEM (1988) (0)
PROSPECTIVE MULTICENTER STUDY FOR TREATMENT OF CHRONIC MYELOCYTIC-LEUKEMIA - COMPARISON OF BUSULFAN, HYDROCYUREA AND INTERFERON ALPHA (UPDATE APRIL, 1990) (1991) (0)
[Autoimmune thrombocytopenia--a therapeutic challenge]. (2010) (0)
[Early phases and prestages of acute leukemia]. (1973) (0)
[Nomenclature of erythrocytoses]. (1978) (0)
Immunosuppressive Therapy (IT) of Severe Aplastic Anemia (SAA) with ATG, Prednisolone (PRED) and Cyclosporin A (CSA) (1985) (0)
[Azathioprine treatment of panmyelopathy with severe amegakaryocytic thrombocytopenia in children]. (1968) (0)
Book Reviews (1869) (0)
Die unklare Anämie – ein differentialdiagnostisches Problem (2007) (0)
Cytotoxic-induced testicular and ovarian dysfunction and impact on quality of life in patients (PTS) treated for hodgkin's disease (HD) after chemotherapy (CT) (1987) (0)
[Hypercalcemia and kidney failure as early symptoms of acute leukemias]. (1972) (0)
[Hereditary nonspherocytic hemolytic anemia with high erythrocyte ATP]. (1969) (0)
Faculty Opinions recommendation of Iron overload in MDS-pathophysiology, diagnosis, and complications. (2011) (0)
[Animal experimental study on erythrocyte labelling with radioactive diisopropylfluorophosphate (DFP32) in animals]. (1964) (0)
[A prospective study on course and prognostic criteria in "preleukemia" (author's transl)]. (1979) (0)
BENEFITS AND PROBLEMS OF INTERDISCIPLINARY CANCER CONFERENCES (1990) (0)
Book reviews (1984) (0)
Drug treatment or stem cell transplantation as primary treatment for patients with CML (2007) (0)
[Studies on the determination of erythrocyte survival time and site of degeneration of erythrocytes in healthy subjects with the aid of Cr51 labelling in vitro and in vivo]. (1962) (0)
Bone marrow transplantation for severe aplastic anemia: Ulm experience [proceedings]. (1978) (0)
Book reviews (1982) (0)
[Studies on hemoglobin synthesis in erythrocytes. II. Formation of Fe59-hemoglobin in peripheral human erythrocytes in vitro]. (1967) (0)
Book reviews (2004) (0)
Repertorium Germanicum IV (Martin V. 1417–31), 2. u. 3. Teilband bearb. ν. Κ. A. Fink (1959) (0)
INFECTIONS ASSOCIATED WITH MALIGNANT DISEASES (1984) (0)
Book Reviews (1872) (0)
[Anemias - old problems and new aspects]. (1975) (0)
Budd-Chiari Syndrome and Other Abdominal Thromboses in the Chronic Myeloproliferative Disorders (1993) (0)
Die Retikulozytenzahl in der Sportmedizin: physiologische und pathophysiologische grundlagen Reticulocyte Count in Sports Medicine: Physiological and Pathophysiological Principles (2010) (0)
CD54 Expression and Its Role in Homotypic Aggregation of the Blasts of Acute Myeloblastic (AML) and Acute Lymphoblastic Leukemia (ALL) (1997) (0)
[Therapy of acute leukemia occuring after panmyelopathy]. (1977) (0)
[The chance diagnostic finding of thrombocytopenia]. (2005) (0)
[Tolerance of a new intravenously applied immunoglobulin preparation and its effect on serum globulin levels]. (1982) (0)
NEKROLOGE: Walter Kaemmerer (1979) (0)
Book reviews (1983) (0)
[Use of patient isolators in the intensive chemotherapy of acute leukemia]. (1969) (0)
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]. (1991) (0)
NEW OBSERVATIONS, AND PRACTICAL ASPECTS OF DIAGNOSIS AND THERAPY (2007) (0)
[Development of medical competence in the "Internal Medicine Block Practice"]. (1994) (0)
[GvH reaction and bone marrow morphology following allogenic bone marrow transplantation]. (1983) (0)
[Studies on blood turnover in posthepatitis and other functional hyperbilirubinemias]. (1962) (0)
Dedication to Sunitha N. Wickramasinghe (2011) (0)
[Blood turnover studies with Cr51 in posthepatic and other functional hyperbilirubinemias]. (1961) (0)
Case conference on integrative medicine—Results of an experiment and future perspectives of a new interdisciplinary approach (2009) (0)
Frequency of congenital dyserythropoietic anemias in (2010) (0)
[Progressive pulmonary fibrosis due to combined treatment with BCNU, cyclophosphospahmide and cytosin-arabinoside (author's transl)]. (1978) (0)
[Clinical course and pathogenesis of panmyelopathy]. (1983) (0)
[Transitory cryoglobulinemia in chronic dysgammaglobulinemic hepatitis]. (1969) (0)
Long-term Follow Up of a Prospective Multicenter Trial with a High-Dose Cytosine Arabinoside and Daunorubicin Postremission Therapy in Adults with De Novo Acute Myeloid Leukemia (1997) (0)
[43-year-old patient with fever, pharyngitis and polyarthralgia]. (1994) (0)
[Erythrocyte morphology and its diagnostic significance]. (1971) (0)
[The use of an alternative healing procedure in women with early-stage breast cancer]. (1999) (0)
[Effect of national and local guidelines on medical practice. Experience with 30 years of internal guidelines in hematology]. (2003) (0)
A Clinicopathological Study of Bone-Marrow Transplant Associated Pulmonary Disease (1985) (0)
[Drugs and acute agranulocytosis: analysis of previous drug intake in 42 patients (author's transl)]. (1979) (0)
[THE CLINICAL SIGNIFICANCE OF THE THYROGLOBULIN LATEX TEST]. (1964) (0)
SERUM HAPTOGLOBIN AS RELATED TO RED CELL TURNOVER RATE ESTIMATED BY CR-51 OR DFP-32. (1964) (0)
Letter from the editor (2006) (0)
Allogeneic Bone Marrow Transplantation in Patients with Acute Leukemia with More Advanced Disease (1992) (0)
[Plasma cell leukemia Ig A paraproteinemia]. (1969) (0)
[Chronic cold agglutinin disease in simultaneous immunologic thyroiditis]. (1970) (0)
diagnostic approach Congenital dyserythropoietic anemias: molecular insights and (2013) (0)
leukemia in adults Intensified therapy in acute lymphoblastic and acute undifferentiated (2011) (0)
VENESECTION THERAPY IN POLYCYTHEMIA-VERA - IRON SUBSTITUTION, YES OR NO (1984) (0)
[Early and late changes in granulocytopoeisis in intermittant adjuvant chemotherapy of breast carcinoma]. (1978) (0)
Emerging Marrow Fibrosis Is an Early Indicator of Imatinib Failure and Shortened Survival Time in CML Independent of Hematologic, Cytogenetic and Molecular Response. (2005) (0)
Book Reviews (1926) (0)
Estimation of Platelet Survival Time Using Chromium51 in Patients with low Platelet Counts (1972) (0)
Kinetics of relapse of leukemia after bone marrow transplantation: cytogenetic follow up of patients with chronic myelogenous leukemia. (1991) (0)
10. In vivo Knorpelsynthese durch Chondrocytentransplantate im Tiermodell In Vivo Synthesis o/Cartilage After Transplantation o/Chondrocytes in (1980) (0)
[Chronic myeloid leukemia--latest aspects and practical progress in recent years]. (1995) (0)
CONGENITAL DYSERYTHROPOIETIC ANEMIAS NEW OBSERVATIONS , AND PRACTICAL ASPECTS OF DIAGNOSIS AND THERAPY By Hermann Heimpel Medizinische Universitätsklinik (2007) (0)
[Comparison of cytological and cytochemical classification in 47 cases of acute leukaemia]. (1972) (0)
[Control hematologic patterns in relation to the whole body dose following 131-I incorporation]. (1968) (0)
[Thoracic-duct lymph drainage: day-night rhythm of lymph flow in patients with malignant nonHodgkin's lymphomas and relative lymphocytopenia of the lymph in chronic lymphatic leukemia]. (1975) (0)
Isotopes in the clinical investigation of dyserythropoiesis. (1977) (0)
[Advantages and problems of interdisciplinary tumor conferences]. (1990) (0)
Allogeneic BMT in Patients with AML: Influence of the Prior Response to Induction Chemotherapy on Outcome After BMT (1996) (0)
[Congenital dyserythropoietic anemias]. (1970) (0)
[Parenteral iron replacement: indications and risks]. (2001) (0)
Allogeneic Bone Marrow Transplantation in Patients with AML in First Complete Remission: Prognostic Factors for Survival? (1994) (0)
Obituary — Jan Neuwirt (1995) (0)
To the Editor: (1988) (0)
[Determination of thrombocyte life span with diisopropylfluorophosphate (DF-32 P)]. (1966) (0)
Letter: Technetium-labeled red cells. (1973) (0)
[Course and prognosis of panmyelopathy under modern therapeutic conditions]. (1973) (0)
ASPIRATION AND NEEDLE-BIOPSY AT POSTERIOR ILIAC CREST (1978) (0)
Book reviews (2004) (0)
[Clinical bone marrow transplantation--indications and results]. (1987) (0)
[Functional hyperbilirubinemia and related disorders of bilirubin metabolism]. (1966) (0)
[Chronic malignant histiocytosis: 5 cases of a special form of lympho-reticular systemic disease]. (1977) (0)
[Erythrocyte elimination and erythrocyte turnover in various hereditary hemolytic anemias]. (1968) (0)
New information on known diseases (1996) (0)
[The effect of carotid sinus release on heat production and circulatory dynamics of the kidney]. (1959) (0)
[Nuclear shadow in lymphocytic leukemia]. (1973) (0)
[Talking medicine contra alternative medicine?]. (1995) (0)
Critical analysis of granulocyte function in 154 patients with different diseases (1982) (0)
[Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation]. (1994) (0)
The Pattern Of Cytogenetic Aberrations In CML BC Stratified For Treatment (2013) (0)
[Problem of reactive hyperemia of the kidneys]. (1958) (0)
Micromapping of very rare anemias: the model of CDA (2013) (0)
[Studies on the leukocyte turnover with radioactive diisopropylfluorophosphate (DF32P) under special consideration of myeloproliferative disorders]. (1966) (0)
[Iron metabolism disorders]. (2009) (0)
SPLENOMEGALY - PAST AND PRESENT (1984) (0)
Treatment of chronic granulocytic leukaemia (CGL) with allogeneic bone-marrow transplantation (BMT) (1986) (0)
[WOULD THE ADDITION OF VITAMIN E PROLONG THE VIABILITY OF TRANSFUSED ERYTHROCYTES?]. (1964) (0)
chronic lymphocytic leukemia Tumor necrosis factor induces proliferation of neoplastic B cells from (2011) (0)
Book reviews (2004) (0)
Book reviews (1983) (0)
[Experiences with bone-marrow transplantation in serious panmyelopathies]. (1976) (0)
Title Pages / Table of Contents (2010) (0)
[Autoimmune diseases of blood cells and hematopoiesis]. (1990) (0)
[On the erythropoietic effect of different tissue suspensions]. (1966) (0)
Genetic anemia in three siblings associated with a nonsense codon of STEAP3 and low expression of the normal allele (2010) (0)
GvHD prophylaxis in allogeneic bone marrow transplantation using t-cell depletion by campath i and complement (1986) (0)
The determination of plasma iron - useful, unnessary or misleading? (2003) (0)
[Hyperhemolysis in patients with operated and not operated on heart valve defects]. (1968) (0)
[Clinical and cytogenetic studies in preleukemic states]. (1973) (0)
[Pro and con: Panmyelopathy: stem cell or autoimmune disease. Arguments for a disease of hemopoietic stem cells]. (1980) (0)
[Hyposiderinemia and anemia in Crohn disease]. (1984) (0)
[Relative deficiency of glutathione reductase and or pyruvate kinase in erythrocytes in aplastic anemia and acute leukemia]. (1971) (0)
["Routine laboratory screen". Cost saving in the hospital laboratory]. (1998) (0)
[Physiopathology of Rh-prevention. Elimination of rhesus-positive radio-chromium labeled umbilical cord erythrocytes in rhesus-negative persons after application of anti-D-serums]. (1970) (0)
HEMATOLOGICAL SIDE-EFFECTS OF ANALGESIC AND ANTIINFLAMMATORY DRUGS (1989) (0)
The potential immune mechanism in a case of methimazole-induced agranulocytosis. (1988) (0)
FINE-NEEDLE ASPIRATION CYTOLOGY OF THE SKIN - VALUE IN THE DIAGNOSIS OF BENIGN AND MALIGNANT LESIONS (1989) (0)
[Pathogenesis and etiology of peripheral pancytopenias]. (1976) (0)
[Behavior of lymphatic subpopulations under cytostatic therapy]. (1978) (0)
INDICATION AND CARRYING OUT OF SUBSTITUTION OF VARIOUS TYPES OF BLOOD CELLS. (1969) (0)
[The binding of radioactive diisopropylfluorophosphate (DFP32) by erythrocytes in vitro]. (1964) (0)
THE CLINICAL TOLERANCE OF A NEW GAMMA-GLOBULIN PREPARATION FOR INTRAVENOUS USE AND ITS EFFECT ON THE SERUM IMMUNOGLOBULIN CONCENTRATION (1982) (0)
myeloid leukemia Drug treatment is superior to allografting as first-line therapy in chronic (2013) (0)
[Current leukemia therapy]. (1969) (0)
UPDATE ON THE EUROPEAN CONSORTIUM FOR CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II (1999) (0)
Correlation between the expression of myelomonocytic surface antigens and ultrastructural demonstration of early myeloperoxidase expression in null-AL(L) cells. (1990) (0)
[Chronic myeloproliferative diseases. New knowledge about well known diseases]. (1996) (0)
Subject Index, Vol. 76, 1986 (1986) (0)
[Panmyelopathy caused by environmental chemicals? The role of chlorinated hydrocarbons]. (2008) (0)
[THE SIGNIFICANCE OF QUANTITATIVE HAPTOGLOBIN DETERMINATION IN THE DIAGNOSIS OF HEMOLYTIC DISEASES]. (1964) (0)
Leukocyte transfusion for treatment of a chronic myeloid leukemia relapse following allogeneic bone marrow transplantation (1994) (0)
[Congenital myelo-monocytic leukemia with aneuploid stemline]. (1970) (0)
Response: Drug treatment and allografting as first-line therapy in young patients with CML (2007) (0)
[Growth of erythropoietic precursor cells (CFU-E) in patients with panmyelopathy]. (1978) (0)
[Studies on the lifetime of human blood platelets with radioactive diisopropylfluorophosphate (DEP32)]. (1966) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hermann Heimpel?

Hermann Heimpel is affiliated with the following schools:

Hermann Heimpel's Academic­Influence.com Rankings

Why Is Hermann Heimpel Influential?

Hermann Heimpel's Published Works

Published Works

What Schools Are Affiliated With Hermann Heimpel?

Hermann Heimpel's AcademicInfluence.com Rankings